Chronic kidney disease in America, Africa, and Asia: Overview of treatment cost and options

Ann Pharm Fr. 2024 Jan 11:S0003-4509(24)00002-6. doi: 10.1016/j.pharma.2024.01.002. Online ahead of print.ABSTRACTChronic kidney disease (CKD) is one of the non-infectious diseases that threaten patients' lives on a daily basis. Its prevalence is high, but under-reported by patients and those living with the disease, as it is silent and asymptomatic in the early stages. Kidney disease increases the risk of heart and vascular disease. These problems can manifest themselves slowly, over a long period of time. Early detection and treatment can often prevent chronic kidney disease from worsening. As kidney disease progresses, it can lead to kidney failure, requiring dialysis or a kidney transplant to stay alive. In this narrative review, we will mainly discuss different treatment option costs in different countries and how much they cost healthcare systems in countries in three different continents.PMID:38218427 | DOI:10.1016/j.pharma.2024.01.002
Source: Annales Pharmaceutiques Francaises - Category: Drugs & Pharmacology Authors: Source Type: research